128
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Serum uric acid and target organ damage in essential hypertension

&
Pages 253-261 | Published online: 02 May 2014

References

  • ChobanianAVBakrisGLBlackHRJoint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureNational Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension20034261206125214656957
  • WhitworthJAWorld Health Organization, International Society of Hypertension Writing Group2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertensionJ Hypertens200321111983199214597836
  • British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke AssociationJBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practiceHeart200591Suppl 5v1v5216365341
  • SalakoBLOgahOSAdebiyiAAUnexpectedly high prevalence of target-organ damage in newly diagnosed Nigerians with hypertensionCardiovasc J Afr2007182778317497043
  • CannonPJStasonWBDemartiniFESommersSCLaraghJHHyperuricemia in primary and renal hypertensionN Engl J Med196627594574645917940
  • European Society of Hypertension-European Society of Cardiology Guidelines Committee2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032161011105312777938
  • CulletonBFLarsonMGKannelWBLevyDSerum uric acid and risk for cardiovascular disease and death: the Framingham Heart StudyAnn Intern Med1999131171310391820
  • DuffyWBSenekjianHOKnightTFWeinmanEJManagement of asymptomatic hyperuricemiaJAMA198124619221522167289015
  • FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
  • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final reportCirculation2002106253143342112485966
  • de JongPECurhanGCScreening, monitoring, and treatment of albuminuria: Public health perspectivesJ Am Soc Nephrol20061782120212616825331
  • DevereuxRBDetection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methodsHypertension198792 Pt 2II19II262948914
  • GanauADevereuxRBPickeringTGRelation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertensionCirculation199081125362297829
  • ViazziFParodiDLeonciniGSerum uric acid and target organ damage in primary hypertensionHypertension200545599199615781669
  • PoudelBYadavBKKumarAJhaBRautKBSerum uric acid level in newly diagnosed essential hypertension in a Nepalese population: a hospital based cross sectional studyAsian Pac J Trop Biomed201441596424144132
  • EmokpaeAMAbduASerum uric acid levels among Nigerians with essential hypertensionNiger J Physiol Sci2013281414423955405
  • RussoCOlivieriOGirelliDGuariniPCorrocherRRelationships between serum uric acid and lipids in healthy subjectsPrev Med19962556116168888330
  • NanHQiaoQDongYThe prevalence of hyperuricemia in a population of the coastal city of Qingdao, ChinaJ Rheumatol20063371346135016821269
  • IwashimaYHorioTKamideKRakugiHOgiharaTKawanoYUric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertensionHypertension200647219520216380520
  • ReynoldsTMSerum uric acid and new-onset hypertension: a possible therapeutic avenue?J Hum HypertensEpub 1162014
  • SundstromJSullivanLD’AgostinoRBRelations of serum uric acid to longitudinal blood pressure tracking and hypertension incidenceHypertension200545283315569852
  • TsouliSGLiberopoulosENMikhaildisDPElevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystanderMetabolism2006551012931230116979398
  • JohnsonRJKangDHFeigDIs there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension20034161183119012707287
  • TsioufisCChatzisDVezaliEThe controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damageJ Hum Hypertens200519321121715647779
  • DmitrievVAOshchepkovaEVTitovBN[Is there an association of uric acid level with preclinical target organ damage in moderate-and high-risk hypertensive patients?]Ter Arkh20138595257 Russian24261230
  • NiskanenLKLaaksonenDENyyssönenKUric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort studyArch Intern Med2004164141546155115277287
  • LorellBHCarabelloBALeft ventricular hypertrophy: pathogenesis, detection, and prognosisCirculation2000102447047910908222
  • YoshimuraAAdachiHHiraiYSerum uric acid is associated with the left ventricular mass index in males of a general populationInt Heart J2014551657024463929
  • MatsumuraKOhtsuboTOnikiHFujiiKIidaMGender-related association of serum uric acid and left ventricular hypertrophy in hypertensionCirc J200670788588816799243
  • RaoGNCorsonMABerkBCUric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expressionJ Biol Chem199126613860486082022672
  • YokoyamaTNakanoMBednarczykJLMcIntyreBWEntmanMMannDLTumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytesCirculation1997955124712529054856
  • WatanabeSKangDHFengLUric acid, hominoid evolution, and the pathogenesis of salt-sensitivityHypertension200240335536012215479
  • KjeldsenSEDahlöfBDevereuxRBLIFE (Losartan Intervention for Endpoint Reduction) Study GroupEffects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudyJAMA2002288121491149812243636
  • RekhrajSGandySJSzwejkowskiBRHigh-dose allopurinol reduces left ventricular mass in patients with ischemic heart diseaseJ Am Coll Cardiol201361992693223449426
  • ZoccaliCMallamaciFUric acid, hypertension, and cardiovascular and renal complicationsCurr Hypertens Rep201315653153724072559
  • FeigDIKangDHJohnsonRJUric acid and cardiovascular riskN Engl J Med2008359171811182118946066
  • ŞerbanCDrăganSChristodorescuRAssociation of serum uric levels and carotid intima thickness with the numbers of organ damaged in hypertensive patientsInternational Journal of Collaborative Research on Internal Medicine and Public Health201131816
  • KlausenKPScharlingHJensenGNew Definition of Microalbuminuria in Hypertensive subjects: Association with Incident Coronary Heart Disease and DeathHypertension200546333715928029
  • AgabitiREMuiesanMLPathophysiology and treatment of hypertensive left ventricular hypertrophyDialogues in Cardiovascular Medicine2005101318